Logo

Helix: Sarah Bobulsky, Craig Newman, Daniel Lee

Jan 14, 2022

Helix has made three new executive appointments. Sarah Bobulsky has been promoted to CFO, Craig Newman has joined as senior VP of health systems and strategic partnerships, and Daniel Lee has joined as senior VP of life sciences and growth.

Bobulksy was previously Helix's VP of commercial and has been with the company for six years.

Newman, who will overseen Helix's expansion of strategic partnerships with health systems, comes to the firm from HealthChannels, where he was chief strategy officer. Prior to that, he spent nine years at The Advisory Board Company, a health systems consultancy.

Lee, who will oversee partnerships with life sciences, payor, and government customers, was most recently senior VP of enterprise modernization at CVS Health. Previously, he spent 17 years at Pfizer, including as VP of consulting and execution.

Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.